Is a 99214 billing code appropriate for an adult patient with poorly controlled diabetes mellitus (DM) using a Tandem (insulin) pump, who had several pump setting changes and serum and urine labs ordered during the office visit?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Billing Code 99214 for Insulin Pump Management Visit

Yes, CPT code 99214 is appropriate for this visit involving a poorly controlled diabetes patient with multiple insulin pump setting adjustments and laboratory orders.

Justification for 99214 Level of Service

The 99214 code requires meeting 2 of 3 key components for established patients: moderate to high complexity medical decision-making, detailed history, or detailed examination 1. This clinical scenario clearly meets these criteria through the following elements:

Medical Decision-Making Complexity

  • Multiple pump parameter adjustments (basal rates, insulin-to-carbohydrate ratios, insulin sensitivity factors) represent moderate to high complexity medical decision-making, as these calculations are individualized and require assessment of total daily insulin dose, weight, exercise patterns, and physiological changes 2

  • Poor glycemic control necessitates review of continuous glucose monitoring data or self-monitoring blood glucose patterns, evaluation of time-in-range metrics, hypoglycemia episodes, and hyperglycemia patterns 2

  • Laboratory ordering (serum and urine studies) adds to the complexity, particularly when assessing for complications, ketosis risk, or metabolic derangements associated with pump therapy 2

Risk Stratification Supporting Higher-Level Coding

  • Patients on insulin pump therapy using only rapid-acting insulin face significant risk of diabetic ketoacidosis within 1-4 hours if pump disconnection, occlusion, or malfunction occurs 2

  • Poor glycemic control increases risk for both acute complications (hypoglycemia, hyperglycemia, ketosis) and requires intensive management adjustments 3

  • The need for multiple pump setting changes indicates the patient is not meeting glycemic targets, which correlates with higher medical decision-making complexity 3

Key Documentation Requirements

To support 99214 billing, your documentation should include:

  • Specific pump parameters changed: Document which settings were adjusted (basal rates for specific time blocks, carbohydrate ratios, correction factors) and the rationale 2

  • Review of glucose data: Time-in-range percentages, hypoglycemia frequency (<70 mg/dL and <54 mg/dL), hyperglycemia patterns (>180 mg/dL), and average glucose 2

  • Assessment of pump complications: Evaluate for infusion set issues, site infections, lipohypertrophy, or technical problems that could explain poor control 2

  • Patient education provided: Document counseling on pump management, sick-day rules, recognition of pump failure, and prevention of diabetic ketoacidosis 2

Common Pitfalls to Avoid

  • Do not code based solely on time unless counseling or coordination of care dominates more than 50% of the visit 1

  • Ensure pump therapy continuation is appropriate: Verify the patient has adequate self-management competencies, supplies, and understanding of pump complications before making multiple setting changes 2

  • Document medical necessity: Poor control despite pump therapy requires assessment of adherence, technique, infusion site rotation, and consideration of whether pump therapy remains the optimal treatment modality 2

  • Consider insulin stacking risk: When adjusting correction factors and carbohydrate ratios, document discussion of the pump's insulin-on-board calculator to prevent excessive corrections 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Insulin Pump Therapy for Type 1 and Type 2 Diabetes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.